These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new approach to treatment of acute heart failure. Goldsmith SR J Cardiol; 2016 May; 67(5):395-8. PubMed ID: 26946929 [TBL] [Abstract][Full Text] [Related]
3. Neurohormonal activation in congestive heart failure and the role of vasopressin. Chatterjee K Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852 [TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR J Cardiol; 2019 Jul; 74(1):49-52. PubMed ID: 30904236 [TBL] [Abstract][Full Text] [Related]
5. Novel strategies: challenge loop diuretics and sodium management in heart failure--part II. Di Pasquale P; Sarullo FM; Paterna S Congest Heart Fail; 2007; 13(3):170-6. PubMed ID: 17541312 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and clinical spectrum of acute congestive heart failure. Shah M; Ali V; Lamba S; Abraham WT Rev Cardiovasc Med; 2001; 2 Suppl 2():S2-6. PubMed ID: 12439355 [TBL] [Abstract][Full Text] [Related]
8. The role of vasopressin in congestive heart failure. Goldsmith SR Cleve Clin J Med; 2006 Sep; 73 Suppl 3():S19-23. PubMed ID: 16970149 [TBL] [Abstract][Full Text] [Related]
9. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment]. Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635 [TBL] [Abstract][Full Text] [Related]
10. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment]. Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306 [TBL] [Abstract][Full Text] [Related]
11. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566 [TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. Albaghdadi M; Gheorghiade M; Pitt B Eur Heart J; 2011 Nov; 32(21):2626-33. PubMed ID: 21672933 [TBL] [Abstract][Full Text] [Related]
13. Neurohormonal activation in heart failure with reduced ejection fraction. Hartupee J; Mann DL Nat Rev Cardiol; 2017 Jan; 14(1):30-38. PubMed ID: 27708278 [TBL] [Abstract][Full Text] [Related]
14. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators. Martin FL; Chen HH; Cataliotti A; Burnett JC Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308 [TBL] [Abstract][Full Text] [Related]
16. Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure. Reed BN; Street SE; Jensen BC Heart Fail Clin; 2014 Oct; 10(4):543-57. PubMed ID: 25217430 [TBL] [Abstract][Full Text] [Related]
17. Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients With Heart Failure? Goldsmith SR; Udelson JE; Gheorghiade M J Card Fail; 2018 Feb; 24(2):112-114. PubMed ID: 29329950 [TBL] [Abstract][Full Text] [Related]
18. Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial. Goldsmith SR; Burkhoff D; Gustafsson F; Voors A; Zannad F; Kolkhof P; Staedtler G; Colorado P; Dinh W; Udelson JE J Card Fail; 2021 Feb; 27(2):233-241. PubMed ID: 33188886 [TBL] [Abstract][Full Text] [Related]
19. Novel strategies: challenge loop diuretics and sodium management in heart failure--Part I. Pasquale PD; Sarullo FM; Paterna S Congest Heart Fail; 2007; 13(2):93-8. PubMed ID: 17392613 [TBL] [Abstract][Full Text] [Related]